Fexofenadine Hcl Tablet
Product Images NDC 11822-7660

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hcl (NDC 11822-7660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rite Aid, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fexo 180mg (Screenshot 2024 12 23 160121)

This is a description of a non-drowsy allergy relief medication in the form of Fexofenadine HCI tablets of 180 mg. It contains an antihistamine and is intended for indoor and outdoor allergy relief, particularly for symptoms like itchy nose or throat.*

FDA Label Image

Fexo 180mg (Screenshot 2024 12 23 160257)

This text is related to allergy relief medication in the form of Fexofenadine HCI tablets USP with 180 mg strength. The medication is non-drowsy and suitable for providing relief for allergies.*

FDA Label Image

Fexo 180mg (Screenshot 2024 12 23 160419)

This text seems to describe allergy relief tablets containing Fexofenadine HCI USP at a strength of 180 mg. The tablets are labeled as non-drowsy, offering relief from allergies without causing drowsiness.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.